NDC 0054-0576

Deferiprone

Deferiprone

Deferiprone is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Deferiprone.

Product ID0054-0576_1bf38cd2-7229-42e1-aec3-70402c17ae39
NDC0054-0576
Product TypeHuman Prescription Drug
Proprietary NameDeferiprone
Generic NameDeferiprone
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2021-06-03
Marketing CategoryANDA /
Application NumberANDA213239
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameDEFERIPRONE
Active Ingredient Strength500 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0054-0576-25

100 TABLET, COATED in 1 BOTTLE (0054-0576-25)
Marketing Start Date2021-06-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Deferiprone" or generic name "Deferiprone"

NDCBrand NameGeneric Name
0054-0576DeferiproneDeferiprone
51672-4196DeferiproneDeferiprone
10122-100FERRIPROXdeferiprone
10122-101FERRIPROXdeferiprone
10122-103FERRIPROXDEFERIPRONE
10122-104FERRIPROXdeferiprone
52609-0006FERRIPROXdeferiprone
52609-0007FERRIPROXdeferiprone
52609-4502FERRIPROXdeferiprone

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.